• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Campbell Appoints Carrie Anderson Chief Financial Officer

    1/25/23 4:30:00 PM ET
    $CPB
    $EMBC
    $IART
    Packaged Foods
    Consumer Staples
    Medical/Dental Instruments
    Health Care
    Get the next $CPB alert in real time by email

    Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230125005725/en/

    Carrie Anderson (Photo: Business Wire)

    Carrie Anderson (Photo: Business Wire)

    Anderson will lead Campbell's finance function, including controllership, corporate financial planning and analysis, corporate strategy and development, tax, treasury, internal audit, investor relations, transactional services and financial systems. She will report to Campbell's President and Chief Executive Officer Mark Clouse and become a member of the company's Operating Committee and a Corporate Officer. Anderson succeeds Mick Beekhuizen, who was appointed President of Campbell's Meals & Beverages division in November 2022.

    "I am delighted to welcome Carrie to our leadership team. She brings a wide range of diverse, strategic experience and financial discipline, and her expertise in capital management and deployment will help us continue to drive our growth plans and enhance our performance," said Clouse. "Her collaborative approach combined with a track record of driving transformation, delivering results and developing strong finance teams will be invaluable as we continue to build momentum in the business."

    Anderson brings a wealth of financial experience working in a variety of complex industries, as well as a background in manufacturing and engineering. She joins Campbell from Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, where she has served as Executive Vice President and Chief Financial Officer since 2019. Before Integra, Anderson spent seven years with Dover Corporation in several leadership roles, including Chief Accounting Officer/Corporate Controller, and Vice President and CFO for the company's engineered systems and printing and identification businesses. Previously, Anderson spent six years as Vice President and Chief Financial Officer of Delphi Product & Service Solutions, a division of Delphi Corporation. While at Delphi, she also held leadership positions in finance, treasury and investor relations. Anderson started her career with General Motors.

    Anderson earned her B.S. in chemical engineering from Purdue University and an MBA from Ball State University. She serves on the board of directors of Embecta Corp. (NASDAQ:EMBC) and is a member of its Audit and Nominating & Governance committees.

    About Campbell Soup Company

    For more than 150 years, Campbell (NYSE:CPB) has been connecting people through food they love. Generations of consumers have trusted Campbell to provide delicious and affordable food and beverages. Headquartered in Camden, N.J. since 1869, Campbell generated fiscal 2022 net sales of nearly $8.6 billion. Our portfolio includes iconic brands such as Campbell's, Cape Cod, Goldfish, Kettle Brand, Lance, Late July, Milano, Pace, Pacific Foods, Pepperidge Farm, Prego, Snyder's of Hanover, Swanson and V8. Campbell has a heritage of giving back and acting as a good steward of the environment. The company is a member of the Standard & Poor's 500 as well as the FTSE4Good and Bloomberg Gender-Equality Indices. For more information, visit www.campbellsoupcompany.com or follow company news on Twitter via @CampbellSoupCo.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005725/en/

    Get the next $CPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CPB
    $EMBC
    $IART

    CompanyDatePrice TargetRatingAnalyst
    Integra LifeSciences Holdings Corporation
    $IART
    7/9/2026$19.00Market Perform
    BMO Capital Markets
    The Campbell's Company
    $CPB
    6/23/2026Mkt Perform
    William Blair
    Integra LifeSciences Holdings Corporation
    $IART
    6/18/2026$25.00Hold → Buy
    Argus
    The Campbell's Company
    $CPB
    6/3/2026$19.00Mkt Perform → Underperform
    Bernstein
    The Campbell's Company
    $CPB
    6/1/2026$21.00Overweight → Equal-Weight
    Stephens
    Integra LifeSciences Holdings Corporation
    $IART
    5/28/2026$16.00Sell → Neutral
    Citigroup
    Embecta Corp.
    $EMBC
    5/6/2026Buy → Neutral
    BTIG Research
    The Campbell's Company
    $CPB
    4/27/2026$21.00Outperform → Mkt Perform
    Bernstein
    More analyst ratings

    $CPB
    $EMBC
    $IART
    SEC Filings

    View All

    SEC Form 11-K filed by The Campbell's Company

    11-K - CAMPBELL'S Co (0000016732) (Filer)

    6/24/26 4:38:25 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    The Campbell's Company filed SEC Form 8-K: Leadership Update

    8-K - CAMPBELL'S Co (0000016732) (Filer)

    6/17/26 4:38:14 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    SEC Form 10-Q filed by The Campbell's Company

    10-Q - CAMPBELL'S Co (0000016732) (Filer)

    6/8/26 7:26:28 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Fin & Princ Acct Officer Mosebrook Jeffrey covered exercise/tax liability with 937 shares, decreasing direct ownership by 3% to 34,516 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    7/6/26 4:43:40 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by EVP & President, SS Singh Harvinder

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    7/6/26 4:42:48 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by EVP & President, TR&DT Davis Robert T. Jr.

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    7/6/26 4:41:42 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

    PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the

    7/16/26 8:00:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Campbell's® Cooks Up New Soup Lineup with 20g of Protein Per Can

    Campbell's Protein Soups come in five delicious varieties, meeting consumer demand for flavor, protein and fiber in every bowlCAMDEN, N.J., July 14, 2026 /PRNewswire/ -- Rooted in real goodness from ingredients like slow-simmered bone broth, white meat chicken, quinoa, beans and lentils, new Campbell's Protein Soups provide a good source of protein and fiber – combining the delicious taste the brand is known for with the nutritional benefits people are looking for as 80% of people actively seek balance in their everyday lifestyles.1 Easy to spot in the soup aisle with a green label, these new offerings include a tasty bone brot

    7/14/26 9:00:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics

    Issued on behalf of Conexeu Sciences Inc.Conexeu Sciences Inc. (NASDAQ:CNXU) completed the 12-month P.R.O.O.F phase of its CXU preclinical program, which met its objectives across three pillars, facial, body, and mechanical performance, as it advances a single-formulation regenerative platform toward a predicate-based 510(k).USA News Group News CommentaryRENO, Nev. , July 9, 2026 /CNW/ -- In regenerative medicine, the durable advantage rarely comes from a single product; it comes from a platform that can be pointed at more than one problem. That is the framing behind a milestone from Conexeu Sciences Inc. (NASDAQ:CNXU), a preclinical-stage regenerative tissue company that has completed the P

    7/9/26 8:16:00 AM ET
    $EOLS
    $ABBV
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    $CPB
    $EMBC
    $IART
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Integra with a new price target

    BMO Capital Markets initiated coverage of Integra with a rating of Market Perform and set a new price target of $19.00

    7/9/26 9:28:53 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    William Blair initiated coverage on The Campbell's Company

    William Blair initiated coverage of The Campbell's Company with a rating of Mkt Perform

    6/23/26 8:22:41 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Integra upgraded by Argus with a new price target

    Argus upgraded Integra from Hold to Buy and set a new price target of $25.00

    6/18/26 8:09:42 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dorrance Bennett Jr bought $6,435 worth of shares (300 units at $21.45) (SEC Form 4)

    4 - CAMPBELL'S Co (0000016732) (Issuer)

    6/10/26 4:07:12 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Director Graves Jeffrey A bought $102,150 worth of shares (9,000 units at $11.35), increasing direct ownership by 28% to 41,086 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    11/6/25 4:05:46 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    5/23/25 4:35:56 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Leadership Updates

    Live Leadership Updates

    View All

    Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

    PRINCETON, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a global leader in medical technology, today announced the appointment of Topaz Kirlew, DBA, MBA, as corporate vice president and chief regulatory officer. Kirlew will lead Integra's global regulatory affairs organization and oversee regulatory strategy, compliance, submissions, and transformation initiatives worldwide. Kirlew served as the interim regulatory leader for the company over the past several months, leading the global regulatory organization during an important period for the company. In her interim capacity, she provided oversight of regulatory compliance, managed activ

    7/2/26 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Integra LifeSciences Announces Key Executive Appointments

    PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Corporation Holdings (NASDAQ:IART), a global leader in medical technology, today announced several leadership appointments within its commercial organization. These changes are designed to strengthen customer focus, accelerate execution, and support the company’s long-term growth strategy. Following the recent appointment of Mike McBreen as executive vice president and chief commercial officer, Robert T. Davis Jr. has been appointed executive vice president, Tissue Reconstruction and Distributed Technologies, where he will lead the wound reconstruction and soft tissue segments, as well as private label. Christopher Ki

    6/23/26 8:00:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    embecta appoints Nimish Muzumdar as SVP and President, North America

    PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that Nimish Muzumdar has been named the company's Senior Vice President and President, North America, effective June 15, 2026. Mr. Muzumdar will be responsible for leading the United States and Canada commercial teams and executing the region's long-term growth strategy. He will report to Dev Kurdikar, Chairman, President and CEO of embecta, and serve on the embecta Operating Team. Mr. Muzumdar most recently served as Senior Vice President & Head, Generics (

    6/16/26 6:30:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Integra LifeSciences Holdings Corporation

    SC 13G - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 5:20:30 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Integra LifeSciences Holdings Corporation

    SC 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 12:54:20 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Embecta Corp.

    SC 13G/A - Embecta Corp. (0001872789) (Subject)

    11/8/24 10:57:43 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Financials

    Live finance-specific insights

    View All

    Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

    PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the

    7/16/26 8:00:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Campbell's Reports Third Quarter Fiscal 2026 Results

    Net Sales decreased 4% to $2.4 billion on a reported and organic basis. Earnings Before Interest and Taxes (EBIT) increased to $239 million; Adjusted EBIT decreased 24% to $274 million. Earnings Per Share (EPS) increased to $0.41; Adjusted EPS decreased 32% to $0.50. Fiscal year-to-date cash flow from operations was $839 million. Reaffirms full-year fiscal 2026 guidance. The Campbell's Company (NASDAQ:CPB) today reported results for its third quarter fiscal 2026 ended May 3, 2026. Unless otherwise stated, all comparisons are to the comparable period in fiscal 2025. CEO Comments: "Our third quarter results were generally in-line with our expectations but remained under pres

    6/8/26 7:15:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    The Campbell's Company to Report Third Quarter Fiscal 2026 Results on June 8, 2026

    The Campbell's Company (NASDAQ:CPB) (Campbell's) announced it will report its financial results for the third quarter fiscal 2026 ended May 3, 2026 on June 8, 2026. A press release, slide presentation, transcript and audio of pre-recorded management remarks will be available at 7:15 a.m. ET. Mick Beekhuizen, President and Chief Executive Officer, and Todd Cunfer, Executive Vice President and Chief Financial Officer will host a live question-and-answer session at 9:00 a.m. ET. Please visit the "Events & Presentations" section of Campbell's investor relations website at investor.thecampbellscompany.com to access these materials and the live Q&A webcast. A full transcript and replay of the

    5/19/26 7:30:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples